LONDON (AFX) - Provexis PLC said it has entered into a long-term collaboration agreement with Unilever PLC to jointly develop a new concentrated format of its patented Fruitflow heart-health technology for application in Unilever's food product portfolio.

Financial details of the deal were not disclosed.

The partners plan to enter into a global licence arrangement for the technology.

Fruitflow is a patented natural extract from tomato which Provexis said has been shown in human trials to reduce the propensity for aberrant blood clotting that is typically associated with cardiovascular disease and which can lead to heart attack or stroke.

In 2005 the market for heart benefit foods was worth 4 bln usd globally, Provexis added.

Considering the growth potential this share has a target of about 8-10p in the medium tern and is a good buy at current levels

As usual, pls do ur own research.

rf are you a shorter then?

I have never shorted in my life...would love to try it out one day : but I have to be sure..the trouble with shorting is that you can nearly always pick out a riser and go for that, shorting is very tricky...but I wouldn't risk it on this one...at the moment.

More of a gradual rise this time. More stability. When the ec wording confirmation comes through. Which imo is granteed too be in one form or another, the deals will follow and that will justify the valuation and way more. aimvho, dyor, gl, fib.

RF ...... i would agree with you 120% were it not for the consistent strength linked to consistently high volumes - 20m today; norm 9.5m and yesterday may have been heavier still, but i can't remember

And the bulls will turn into bears just like that on this one....75 million and 5000 earnings : I mean : turning tomatoes into gold might justify this valuation....I just can't bring myself around to jumping back in here...I thought it was a miracle last time I made a small buck...

Are these people going to produce the aspirin replacement ?....it's going to take ages before the Americans allow this into their airspace....a big boy participation is a must be for this now...Glaxo, Unilever and sorts spring to mind...

i cannot disagree one iota with your logic, but just maybe there is more to this headlong rush for the stars than mere lemming hype - e.g. an announcement that a licencing deal has indeed been struck with Coca Cola or similar

Well...if that is the case then possibly zoom....but I prefer my oilies...too risky for me in case of a no show from the soft drink people...

and oilies aren't?????????

cynic you may be right but it has to be a massive deal to justify a market cap of around 100m.

quite so or t/o, so i am contemplating my navel accordingly

required field, to quote "a major order for whatever it does"

do you know anything about this company, its products, research, agreements or current situation? Agreed it has a high valuation and has low revenue but it has had an agreement with unilever and coca cola for the last two years plus. It is the only company that has an approved EC scientific claim for food under article 13.5.
It is about to announce trial results from comparisons with aspirin for health benefits.
It has a major shareholder in DSM which is the worlds top 3 ingredients producer/developer. It has directors with connections to a major pharmaceutical company.

All of this is lining up to produce sizeable revenues - agreed we are not aware of details as yet but the markets for the product is huge, in the multi billion range for both food and also alternative to daily aspirin as preventitive therapy.

The current key announcement is the final EC wording approval. Whether this swings around some more, the sp has made and will keep its major change from its previous ranges.

GM .... the first and last parts of your post seem to contradict each - e.g. how can PXS already have agreements in place when EC has not, as far as i determine, actually agreed to the marketing of PXS's snake oil .... thus, PXS can only have letters of intent at best

if i am wrong, as many tell me is always the case, then please clarify for my aged and addled brain

It's a pharma Stanelco....here we go again...there's a thousand companies all promising the eldorado out there...all with markets they say running into billions...have you ever watched "dragons den" when these entrepreneurs (some of them very very hard working people) come on with a godforsaken product that they say there is a market running into hundreds of millions of pounds for them !, : directors with connections...? so has everybody !....no this has me convinced that this could be a promising young company but massively overvalued...another SEO !.

Cynic: Coca-Cola had signed an exclusive agreement with Provexis back in November 2007 to assess their Fruitflow technology. See link below:

PXS - RNS dated 15 November 2007

It was on the strength of that, plus the Unilever agreement, that I had bought a load of shares at the time - but subsequently sold when it all nose-dived (though I'm back in now). However, it seems that it has all just taken a lot longer than anticipated. The Fruit should finally be ripening into a a good Flow of cash!

The above 12-month agreement was extended to 31 March 2009. Presumably, having assessed it, they are now in negotiations for a deal - as stated in their CEO's Statement of 09 June 2009 (in PXS end-of-year audited results): "We are in advanced license negotiations with a leading global ingredients manufacturer with global reach and strategic relationships with a wide range of global brand owners, in addition to an extensive customer base of regional brand owners. These negotiations are focused on rights for all food, beverage and dietary supplement applications."

etc etc - I could go on but I'm quite sure you're capable of dyor.

The sp is already up with events, it would take an incredible optimistic rns to send this past 20p...but I suppose if the whole world buys the shares it will rise even if there is just 5000 worth of earnings....it takes some doing to put a valuation of 80 million on a company....the sp is up with events and well ahead...there has to be a massive contract and sale of products coming to justify this price tag....and beware of another EK short coming....

There's also this, taken from an article at around that time (19 November 2007) re Unilever's involvement:

"The original Fruitflow is a thick, sugary syrup - ideal for juice drinks like Sirco but with a strong flavour and colour that makes it unsuitable for dairy and other foods. An existing agreement with branding giant Unilever is intended to solve this, and Provexis indicated in its interim results that this partnership will be extended by another 12 months."

Hope this helps

The CEO has said they have contracts in the pipeline ready to go once the official EU approval is rec. on the wording to be used. These multi national cos will hold back until then but we already know that one has a major stake in the co.--others are probably lining up for a piece of the action assuming the extract can be used in a variety of products for differing medical conditions. The CEO also said penicillin was produced by a small team of 6 scientists--when quizzed about his tiny co.
sirco--also good for addled brains to increase the blood flow!! lol.

Toya---snap!

Worth 80 million.....pleeezzze....it's nonsense....even if there is a big contract coming they will only take a percentage...it's like a farmout for an oil company....are we all going to be taking fruity fruitflow instead of nurofens now ?....perhaps not !.